Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
FIPRONIL
Merial Animal Health Limited
QP53AX15
FIPRONIL
0.25 %w/v
Cutaneous Spray Solution
POM
Canine, Feline
Fipronil
Ectoparasiticide
Authorised
1995-07-07
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Frontline Spray 0.25% w/v 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Fipronil 0.25 % w/v For a full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Cutaneous spray, solution. A clear solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The treatment and prevention of infestation by fleas and the treatment and control of ticks in dogs and cats. The product rapidly controls infestations with _Trichodectes canis _biting lice of dogs and _Felicola subrostratus _biting lice of cats. Treatment with Frontline Spray has been shown to significantly reduce the incidence of flea allergy dermatitis in both dogs and cats. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance. Do not use on sick (systemic diseases, fever…) or convalescent animals. Do not use Frontline Spray in rabbits as adverse reactions and even death could occur. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 12/08/2016_ _CRN 7023301_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES For external use only. Avoid spraying in the animals’ eyes. Do not spray directly onto areas of broken skin. Ticks will usually detach from the treated host within 24 to 48 hours after infestation, without having had a blood meal. However, some ticks may attach. For this reason, transmission of infectious diseases by ticks cannot be completely prevented. Treatment of bedding, carpets and soft furnishings with a suitable insecticide will aid reduction in environmental challenge and maximise the duration of protection against re-infe Preberite celoten dokument